Prime Medicine, Inc. (PRME)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Prime Medicine, Inc. reported revenue of $4.63M, up 55.3% from the prior year. The company ran a net loss, with a net margin of -4342.4%. It held $342.73M in total assets against $221.87M in total liabilities.
Key ratios (FY2025)
-4498.1%
Operating margin
-4342.4%
Net margin
-166.4%
Return on equity
+55.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $4.63M | $2.98M | $0 | $0 | $0 | $5.21M | — |
| Operating Income | -$208.35M | -$202.47M | -$204.79M | -$116.54M | -$84.47M | -$932.0K | — |
| Net Income | -$201.14M | -$195.88M | -$198.13M | -$121.82M | -$165.37M | -$3.41M | — |
| EPS (Diluted) | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 | $-1.91 | — |
| Total Assets | $342.73M | $297.51M | $193.85M | $360.31M | $301.86M | — | — |
| Total Liabilities | $221.87M | $144.36M | $60.78M | $44.04M | $62.30M | — | — |
| Shareholders' Equity | $120.87M | $153.15M | $133.07M | $316.27M | -$156.24M | $2.34M | -$2.60M |
| Cash & Equivalents | $63.03M | $182.48M | $41.57M | $187.62M | $185.42M | $36.98M | — |
| Operating Cash Flow | -$162.56M | -$122.86M | -$165.41M | -$131.83M | -$34.08M | -$5.54M | — |
| Capital Expenditures | $4.53M | $7.29M | $8.72M | $16.09M | $4.15M | $639.0K | — |
| Shares Outstanding | 148.76M | 118.60M | 90.97M | 33.89M | 12.97M | 2.64M | — |